SUMMARY The oral administration of loxtidine to mice at doses of 600, 250, and 50 mg/kg/day for 746 days produced carcinoid tumours of the gastric fundus. The fundic mucosa also showed marked atypical hyperplasia with changes in foveolar cells similar to those seen in early incomplete metaplasia. These effects may be related to the prolonged achlorhydria produced by this potent unsurmountable histamine H2 receptor antagonist. antagonist.10 Its administration to rodents produces unremitting achlorhydria and in rats treated for prolonged periods the late development of carcinoid tumours of the fundus." The present communication describes the more extensive and different gastric changes seen in mice which were given loxtidine for 107 weeks, a major part of their normal life span.
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Methods

ANIMALS
Loxtidine was administered daily in the drinking water to mice of the C57BL/lOScSn strain from the age of 6-8 weeks onwards. Treatment continued for 107 weeks. It was calculated that mean dose levels of 50, 250, and 600 mg/kg/day were attained. Precise plasma levels of loxtidine were measured by the method of Harrison et al. 12 There were 55 male and 55 female mice in each treated group and 105 mice of each sex in the untreated control groups. The animals were inspected frequently for signs of illness and also palpated to detect swellings. Each mouse found dead, or killed was subjected to a careful post mortem examination. Mice were housed five to a cage and fed Mouse No. 1 expanded diet. * The techniques used in this study were similar to those used in our previous study in the rat.
Results
SURVIVAL
Treatment with loxtidine did not affect survival and after 107 weeks the percentage of each group can be seen in Table 1. PLASMA CONCENTRATIONS OF LOXTIDINE Appreciable levels were always seen in the high dose group (3870-12047 ng/ml) and in the intermediate group (821-2290 ng/ml) but at the low level considerably less was found (132-268 ng/ml). (Fig. 1) . Histological examination revealed a sequence of changes from minimal mucosal proliferation to marked bizarre exuberant and extensive proliferation (Fig. 2) . The earliest histological change, mucosal thickening, was seen in a male mouse, treated at the high level for 161 days.
Few mice died between days 161 and 590, by which time the mucosa was thrown into folds giving a polypoid appearance. Scattered dilated glands of variable size and distribution, often with cyst formation were seen ( Fig. 2) but no ulcers were found.
In association with these changes there were obvious disturbances of the normal cellular patterns. The gastric pits were elongated often with irregular, tortuous contours and obvious branching (Fig. 3) . The surface epithelium showed hyperplasia and a disorderly arrangement of cells. There were some mitotic figures and apopotic bodies were common. In addition some nuclei tended to be heaped up and to have variable staining affinity size and shape. Evidence of a change in the quality of mucus was seen. In untreated mice neutral mucin predominated, acidic mucin being found only in the pyloric glands and in trace amounts at the mucosquamous junction. In the hyperplastic mucosa of the treated mice acidic mucin was found in the fundic region in quantities similar to neutral mucin. The acidic mucin was predominantly sialomucin of the N-acylated variety but small amounts of sulphomucin were also found.
Electron microscopy showed that the normal, neutral mucin secreting, foveolar cells in control mice contained dense staining mucous granules concentrated into the apical region. None showed obvious microvilli although in some there was an odd protuberance (Fig. 4) . This was in contrast with the foveolar cells containing acid mucin which had less dense mucous granules of variable size with no apical concentration. All these cells had a number of poorly developed, scattered and irregularly arranged microvilli (Fig. 5) . (Fig. 7) where they were seen as large nodular aggregates. In one case invasion of the muscle wall of the stomach was seen and in two cases malignant cells with large nuclei were found in draining lymph nodes (Fig. 8) .
Diazo and Grimelius techniques showed that in untreated mice the neuroendocrine cells of the glandular fundic stomach were predominantly argyrophilic and were scattered in the lower half of the mucosa. Argentaffin cells occurred chiefly in the glands of the pylorus. In loxtidine treated mice showing proliferation of the fundic mucosa, there was a general increase in the numbers of argyrophil cells throughout the mucosa. The aggregates of pale cells were consistently argyrophilic as were the cells forming deposits beneath the muscularis mucosae and those found in the lymph nodes (Fig. 8) .
Ultrastructural show histamine and histidine decarboxylase were not used.
Discussion
Although loxtidine is not a genotoxic carcinogen" mice treated for two years did develop marked proliferative changes in the fundic area of the stomach. These changes satisfy the criteria for 'atypical hyperplasia'.
l In addition, many exhibited focal aggregates of argyrophilic cells which were positive for neurone-specific enolase and which, with electron microscopy, were found to contain typical neurosecretory granules. These characteristics denote the carcinoid nature of the aggregates. There was evidence of local invasion and in two cases metastatic deposits were found in lymph nodes. No specific functional activity could be ascribed to the tumours using specific antibody techniques.
No goblet cells were found in any stomach, even when using Alcian blue/PAS stained sections and no Paneth cells were ever recognised. Changes were, seen, however, in the type of mucus present in the foveolar cells and in their ultrastructure. These changes resembled those found in incomplete metaplasia of the human stomach where acidic mucins appear and where microvilli become more evident.15 16 It is perhaps relevant to state that the distribution of mucin types in the mouse stomach closely resembles that seen in man. 17
The gross proliferative changes seen in the majority of mice given loxtidine ( Omeprazole, an H+K+ ATPase inhibitor, also effectively suppresses acid secretion for long periods. Treatment of rats led to fundic carcinoids but at 18 months mice only displayed 'hyperplastic gastrophy'.'18 Unfortunately the study was terminated at this time so that the result of more prolonged treatment is unknown.
The difficulties of attempting to extrapolate results, such as those reported here for mice and those already published for rats,'1 to the human clinical situation, have featured in a leading article in this journal in which the need to avoid prolonged excessive suppression was emphasised. '9 In man an association between polypoidal carcinoid tumours of the stomach, hypergastrinaemia and achlorhydria is known,20 and it was suggested that, 'long term, uninterrupted achlorhydria produced by potent inhibitors of gastric acid secretion might therefore predispose to carcinoid tumours of the stomach'.
A continuous sequence from neuroendocrine cell hyperplasia through microcarcinoidosis is reported21
but not all the factors responsible for this are known. In the rat a relationship between prolonged hypergastrinaemia and ECL hyperplasia has been demonstrated, 22 .~~~~~~~~~~~~~~~~~~. pathogenesis of ECLomas'. It was also pointed out that high levels of a circulating stimulus may perhaps facilitate the development of endocrine cell neoplasia triggered by other stimuli.
The development of loxtidine was abandoned when gastric carcinoid tumours were found in the rat11 and the reasons for this decision have been given.24 Findings in mice have shown that the rat changes are not species specific. The mouse is very susceptible in that as well as developing carcinoid tumours, it shows an atypical hyperplasia of the fundic mucosa with some features suggestive of early incomplete metaplasia. Some of these changes may well be related to prolonged achlorhydria. The fact that there is, in man, a long postulated link between intestinal metaplasia and gastric carcinoma25 provides another reason for adopting a conservative approach.
The reason for performing long term studies in mice and rats is to seek any changes which may be indicative of a possible hazard in treated patients. The extrapolation and significance of these changes to man is, in our present state of knowledge, impossible. Consequently we do not believe that loxtidine should be used for the healing or maintenance treatment of peptic ulcer disease, because there are already effective treatments such as ranitidine26 and cimetidine27 which produce no such changes. 
